drugset

drugset / Trial / NCT07089043

A Study in Subjects With Neurogenic Orthostatic Hypotension

NCT07089043 ↗

Phase 2 Recruiting 12 enrolled CuraSen Therapeutics, Inc.

Non-randomizedSequentialSingle-blindTreatment

Summary

This is a study to evaluate the effects of CST-3056 on orthostatic symptoms and signs in subjects with neurogenic orthostatic hypotension (nOH).

Timeline

Start: 2025-09-12
Primary completion: 2026-07-31
Completion: 2026-08-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CST-3056	Unknown	—	Oral

Indications